100percentfedup.com
The TRUTH About Breast Cancer Awareness Month
To be honest with you all (as I always am) I have never liked the October “Breast Cancer Awareness Month” pink ribbon.
Just always rubbed me the wrong way.
Plus I believe there have been a lot of scandals around where the money actually goes.
It all felt like a bunch of self-congratulatory nonsense that never moved the needle.
I’ve never liked things that suck up all the attention and all the energy and all the money away from making true, actual progress!
And it turns out I wasn’t wrong, because I’d like you to meet my friend Jan James who came back on my show today to essentially tell you the same thing.
Jan is a breast cancer survivor and a fierce advocate for things that actually work!
More on that in a minute.
First I want to show you our interview which I thought was so good — always a treat to have Jan on the show!
Watch here:
Now to go ever deeper, read this:
The 1977 Cover-Up: How Millions of Women Were Denied the Truth About Breast Cancer
The 1977 Cover-Up: How Millions of Women Were Denied the Truth About Breast Cancer
Breast Cancer Awareness Month’s Hidden Story
Every October, pink ribbons flood our communities, reminding us of breast cancer’s devastating toll. Walks, fundraisers, and awareness campaigns dominate the conversation. Yet what most women—and men—don’t know is that overforty-five years ago, a breakthrough could have rewritten the story of breast cancer.
In 1977, Dr. Harold W. Manner, Chairman of the Biology Department at Loyola University in Chicago, and his research team discovered that Laetrile—also known as Vitamin B17 or amygdalin—combined with certain enzymes and vitamin A, had dramatic effects on breast tumors in laboratory studies. Tumors shrank in as many as 89% of cases. Dr. Manner’s bombshell quote at the time:
“Cancer is not a medical problem—It’s a metabolic problem. Mastectomy may now be a thing of the past.”
It should have been front-page news. It should have transformed cancer care. Instead, the research was buried, dismissed, and smeared. The result? Millions of women underwent mastectomies, toxic chemotherapy, and radiation, while a natural therapy with life-saving potential was hidden from them. By conservative estimates, this cover-up has contributed to the deaths of around two million women in America alone since 1977.
This isn’t just a forgotten chapter in medical history—it’s a warning for today. Because the same forces that silenced Dr. Manner in 1977 continue to shape the cancer industry in 2025.
The 1977 Cover-Up: How Millions of Women Were Denied the Truth About Breast Cancer
The Forgotten Breakthrough of 1977
Dr. Manner’s work built on the controversial discoveries of Dr. Ernst T. Krebs, Jr., who isolated amygdalin (Vitamin B17) from Apricot Seeds and proposed its targeted mechanism against cancer cells. By the mid-1970s, Laetrile had already gained public attention—primarily through patients of Dr. John A. Richardson, MD, in San Francisco, who successfully treated thousands with the compound.
But Manner’s animal studies brought something different: laboratory confirmation. In mice and rats, tumors not only stopped growing but regressed significantly. For women facing breast cancer at the time, this could have offered a non-toxic alternative to mutilating surgeries and life-threatening chemo.
Instead of heralding a revolution in oncology, mainstream medicine mobilized to crush it. Funding was cut. Journals refused to publish. Media outlets ran stories branding Laetrile as quackery. The National Cancer Institute (NCI) selectively chose negative studies and overlooked positive data.
One pivotal event was the infamous 1977 Congressional hearings on Laetrile, where patients testified to their survival stories, but government officials doubled down, branding the therapy “unproven” and “dangerous.” Within months, the door slammed shut.
From Mice to Women: The Suppressed Human Trials
In 1977, Dr. Harold Manner at Loyola University reported something extraordinary: in 89% of his test mice, mammary tumors completely regressed when treated with a combination of Laetrile (Vitamin B17), protein-digesting enzymes, and emulsified Vitamin A. Tumors that had consumed up to half the animal’s body weight vanished, leaving behind only small scars.
What came next was even more groundbreaking. By early 1978, Dr. Manner extended his research to human trials. In a workshop on metabolic therapy, he revealed that 15 women with breast cancer had responded to his program to the point of total tumor disappearance.
“The breast cancers of 15 women are already under control … to the point of total disappearance of the tumors—with the program of Vitamin B17, protein-digesting enzymes and emulsified Vitamin A which he first tested on mice at his Loyola University laboratories last year.” – Harold W. Manner, PhD, University of Loyola
These results should have sparked a revolution in oncology. Instead, they triggered outrage. The American medical orthodoxy condemned Manner, ridiculed his work, and ignored the lives that had already been changed. His findings were not celebrated—they were buried.
The Media Blitz: How The New York Times Helped Bury Laetrile
When Dr. Harold Manner’s findings emerged in 1977, it wasn’t just scientists and government agencies that moved to shut the door on Laetrile—it was the press.
Analysis of The New York Times coverage shows that 1977 was the single most aggressive year of demonization in the media’s history with Laetrile. That year alone, the Times published 158 separate articles mentioning Laetrile, the vast majority framing it as dangerous quackery.
The spike is unmistakable. For more than a decade before 1977, Laetrile barely registered in mainstream coverage. Then, suddenly, as Congressional hearings and promising research began making headlines, the Times unleashed a flood of negative stories—more than ten times the coverage of any other year.
And what happened after the firestorm? Silence. In the 23 years since 2000, only 23 articles in The New York Times have even mentioned Laetrile. After the coordinated assault of 1977, the therapy was not only discredited—it was effectively erased from public conversation.
This wasn’t journalism—it was narrative control. The public was repeatedly told that Laetrile was a fraud. Few were ever shown the actual research data. Few heard from the patients who testified in Washington that their lives had been saved. And almost no one was told about Dr. Manner’s animal studies or Dr. Sugiura’s positive findings at Sloan-Kettering.
It is also noteworthy that 1977 was the very year Dr. John A. Richardson, MD published his now-classic book, Laetrile Case Histories: The Richardson Cancer Center Experience. While Dr. Harold Manner was presenting laboratory and early human trial evidence of Vitamin B17’s ability to regress breast tumors, Dr. Richardson was documenting more than 6,000 real-world cases of cancer patients treated with the Richardson Protocol. His case histories revealed consistent patterns of tumor regression, improved quality of life, and in many cases, long-term survival—often after conventional medicine had offered little hope.
Taken together, these two groundbreaking works—Dr. Manner’s laboratory and early clinical research, and Dr. Richardson’s extensive patient case studies—should have formed the foundation of a new era in cancer treatment. Instead, both were aggressively suppressed, buried beneath a campaign of ridicule and regulatory prohibition.
1977 was a manufactured flashpoint: the year Laetrile was buried under an avalanche of press attacks, ensuring it would never be seriously considered again in mainstream medicine. The consequences of that coordinated campaign are still being felt by women battling breast cancer today.
Why the Cover-Up Mattered
To understand the impact, we must grasp what women were facing in 1977. The “standard of care” for breast cancer was the radical mastectomy—complete removal of the breast, chest muscles, and lymph nodes. These surgeries were disfiguring, traumatic, and often unnecessary.
Even the American Cancer Society eventually admitted that many of these mastectomies were avoidable. Yet while women endured this, the most promising non-toxic approach in decades was quietly buried.
This wasn’t a scientific rejection. It was economic and political suppression.
Every time an alternative therapy threatened to gain traction, the medical establishment responded the same way: demand randomized clinical trials (while refusing to fund them), publish negative results (while hiding positive ones), and smear dissenting voices as “charlatans.”
The result: decades of suffering, billions in profits for surgery, chemo, and radiation, and the quiet erasure of a natural therapy that could have changed everything.
Two Million Women Too Many
Let’s put the cost in perspective. Since 1977, about two million American women have died of breast cancer. Even if Laetrile had helped a fraction of them—say, 10%—that would mean 200,000 lives saved.
But Manner’s data suggested much more: tumor regression in nearly 9 out of 10 cases. Even if human outcomes were lower than lab animals, the potential was staggering.
Instead, we got four decades of toxic treatments marketed as “progress.” Yes, survival rates have improved—but largely because of earlier detection, not better therapies. Meanwhile, the number of women diagnosed with breast cancer has skyrocketed, and millions live with the lasting trauma of unnecessary surgeries and toxic drugs.
How the Rigging Works
Some argue, “If Laetrile really worked, science would have proven it by now.” But that ignores how the system is rigged.
Selective Trials: The NCI’s 1980 clinical trial of Laetrile is a case study in sabotage. Patients were given minimal doses, denied complementary nutrients, and already in late-stage disease. The outcome was predetermined to fail.
Scientific Fraud: At Sloan-Kettering Cancer Center, Dr. Kanematsu Sugiura’s animal studies confirmed Laetrile’s anti-cancer effects. Instead of celebrating his results, officials tried to bury them. When whistleblower Ralph Moss exposed the cover-up, he was fired.
Falsified Data: In one notorious case, Sloan-Kettering scientist Dr. William Summerlin literally used a black felt-tip marker to fake results of mouse experiments. Instead of exposing this fraud as part of a larger pattern, the media reported it as an isolated incident.
The point is clear: science can be—and often is—weaponized to protect profits, not patients. As Robert F. Kennedy, Jr., now Secretary of Health and Human Services, recently said: “For too long, HHS has allowed science to be captured by corporate interests. We are committed to restoring gold-standard science—science that serves the people, not the corporations.”
Connecting Then and Now
The tragedy of 1977 isn’t just history—it’s a mirror for today.
Medical Training: Until now, most medical schools required only a few hours of nutrition training. That’s changing: for the first time, nutrition education is becoming a necessary part of U.S. medical training. This is a victory for patients—but it’s decades overdue.
Turbo Cancer: Recent peer-reviewed studies, including a South Korean study of 8.4 million adults, have found alarming increases in cancers—lung, prostate, thyroid, gastric, colorectal, and breast—linked to COVID-19 vaccination. Once again, we’re told “don’t look here” while evidence mounts.
Censorship: Whether it’s Laetrile in 1977 or nutrition and vaccine data in 2025, the playbook hasn’t changed. Suppress, smear, and silence.
Why This Matters for Breast Cancer Awareness Month
Pink ribbons and awareness walks are not enough. Women deserve the whole truth:
Those safe, natural options have been known—and suppressed—for decades.
That medical freedom is as much a woman’s issue as a health issue.
That real progress won’t come from billion-dollar drug trials, but from courageously revisiting the knowledge buried in 1977.
As a breast cancer survivor, I can tell you: awareness without truth is just marketing. We don’t need more slogans. We need honesty, courage, and freedom to choose.
Call to Action
At Operation World Without Cancer, we are carrying forward the legacy of Dr. John A. Richardson, MD, Dr. Harold Manner, and countless other medical pioneers who dared to believe in natural healing. We’ve inherited “The Vault,” a treasure trove of documents, books, and videos that preserve this suppressed knowledge. We’re committed to restoring it to the marketplace of ideas, where it belongs.
Here’s how you can join us:
Shop: Learn more about using B17 to protect your immune system and save 10% by using discount code WLT at https://rncstore.com/wlt
Learn: Download World Without Cancer: The Story of Vitamin B17 for free at myworldwithoutcancer.com. (Or buy the groundbreaking book here: https://rncstore.com/WLT-WWC
Connect: If you or someone you love is facing a diagnosis, visit B17works.com to be referred to a Certified Richardson Protocol Physician.
Support: Donate at OWWC.org. Your gift helps us preserve and publish suppressed research from the past while funding future clinical trials.
Together, we can honor the women lost, support the women fighting now, and prevent future generations from being deceived again.
It’s time to finish what 1977 should have started.
New Posts (Home)
ChatBox
Popular Posts 
Game Zone
Top PodCasts
